Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Dow
AstraZeneca
Citi
UBS
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson

Generated: April 22, 2018

DrugPatentWatch Database Preview

Carboprost tromethamine - Generic Drug Details

« Back to Dashboard

What are the generic sources for carboprost tromethamine and what is the scope of carboprost tromethamine patent protection?

Carboprost tromethamine
is the generic ingredient in one branded drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for carboprost tromethamine. One supplier is listed for this compound.
Summary for carboprost tromethamine
Pharmacology for carboprost tromethamine
Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog
Medical Subject Heading (MeSH) Categories for carboprost tromethamine
Synonyms for carboprost tromethamine
(15S)-15-Methylprostaglandin F(sub 2alpha) tromethamine
(15S)-15-Methylprostaglandin F2alpha tromethamine
(5E)-7-[(1S,3S,5R)-3,5-DIHYDROXY-2-[(1Z,3S)-3-HYDROXY-3-METHYLOCT-1-EN-1-YL]CYCLOPENTYL]HEPT-5-ENOIC ACID; TRIS BUFFER
(E)-7-[(1S,3S,5R)-3,5-dihydroxy-2-[(Z,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(3S)-3-hydroxy-3-methyl-1-octenyl)cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
(Z)-7-[(1R,2S,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid 2-amino-2-(hydroxymethyl)propane-1,3-diol
15-Methyl PGF2 alpha
15-Methyl prostaglandin F2alpha
15-methylprostaglandin F2alpha-tromethamine
15(S)15-Methyl pgf2-alpha tromethamine salt
15(S)15-Methyl pgf2-alpha tromethaminesalt
15(S)15-Methyl prostaglandin F2-alpha tromethamine
2-Amino-2-(hydroxymethyl)propane-1,3-diol (E)-7-((1s,3s,5r)-3,5-dihydroxy-2-((s,z)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept- 5-enoate
2-amino-2-(hydroxymethyl)propane-1,3-diol; (E)-7-[(1S,3S,5R)-3,5-dihydroxy-2-[(Z,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid
2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid
2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid
551C692
58551-69-2
AC1NQXZK
AC1O5I8V
AN-10388
API0007240
C21H36O5
C25H47NO8
carboprost trometamol
Carboprost Trometanol
Carboprost tromethamine (USP)
Carboprost tromethamine [USAN:USP]
Carboprost tromethamine [USAN]
Carboprost Tromethanimine
CHEMBL1237105
D00682
D07PCI
Hemabate
Hemabate (TN)
I06-1950
J-507750
LP015412
LS-125842
N916
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9-alpha,11-alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9-alpha,11-alpha,13E,15S)-,compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prostin / 15M
Prostin/15
RP17766
SC-20243
SCHEMBL1649818
SCHEMBL433085
ST51053306
U 32921E
U-32,921E
U-32921
U-32921E
U4526F86FJ
UMMADZJLZAPZAW-XOWPVRJPSA-N
UNII-U4526F86FJ

US Patents and Regulatory Information for carboprost tromethamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn HEMABATE carboprost tromethamine INJECTABLE;INJECTION 017989-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Mallinckrodt
Cerilliant
Deloitte
Fuji
Harvard Business School
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.